首页> 外文期刊>Toxicology Reports >ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections
【24h】

ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections

机译:ROS介导的光照射核黄素的抗菌活性:抵抗医院感染的光动力机制。

获取原文
       

摘要

Nosocomial infections are a major threat to modern therapeutics. The major causative agent of these infections is multidrug-resistant gram-negative bacteria, which impart high morbidity and mortality rate. This has led to an urge for the development of new antibiotics. Antimicrobial photodynamic therapy is a promising strategy to which till date no resistant strain has been reported. Since the efficacy of photodynamic therapy largely depends on the selection and administration of an appropriate photosensitizer, therefore, the realization of clinically active photosensitizers is an immediate need. Here, by using E. coli as a study model we have demonstrated the antimicrobial photodynamic potential of riboflavin. Intracellular ROS formation by DCFH-DA assay, lipid peroxidation, protein carbonylation, LDH activity was measured in treated bacterial samples. Enzymatic (SOD, CAT, GSH) antioxidants and non-enzymatic (GSH) was further evaluated. Bacterial death was confirmed by colony forming assay, optical microscopy and scanning electron microscopy. The treated bacterial cells exhibited abundant ROS generation and marked increment in the level of oxidative stress markers as well as significant reduction in LDH activity. Marked reduction in colony forming units was also observed. Optical microscopic and SEM images further confirmed the bacterial death. Thus, we can say that photoilluminated riboflavin renders the redox status of bacterial cells into a compromised state leading to significant membrane damage ultimately causing bacterial death. This study aims to add one more therapeutic dimension to photoilluminated riboflavin as it can be effectively employed in targeting bacterial biofilms occurring on hospital wares causing several serious medical conditions.
机译:医院感染是现代治疗方法的主要威胁。这些感染的主要病原体是耐多药革兰氏阴性菌,它具有较高的发病率和死亡率。这导致了开发新抗生素的冲动。抗菌光动力疗法是一种有前途的策略,迄今为止,尚无耐药菌株的报道。由于光动力疗法的功效在很大程度上取决于适当光敏剂的选择和给药,因此,迫切需要实现临床上有效的光敏剂。在这里,通过使用大肠杆菌作为研究模型,我们已经证明了核黄素的抗菌光动力潜力。通过处理的细菌样品中DCFH-DA测定,脂质过氧化,蛋白羰基化,LDH活性的细胞内ROS形成被测量。进一步评估了酶促(SOD,CAT,GSH)抗氧化剂和非酶促(GSH)。通过菌落形成测定,光学显微镜和扫描电子显微镜确认细菌死亡。处理过的细菌细胞表现出大量的ROS生成,氧化应激标志物水平显着增加,LDH活性显着降低。还观察到菌落形成单位的显着减少。光学显微镜和SEM图像进一步证实了细菌的死亡。因此,我们可以说光照射的核黄素使细菌细胞的氧化还原状态变为受损状态,从而导致明显的膜损伤,最终导致细菌死亡。这项研究的目的是为光照射的核黄素增加一个治疗角度,因为它可以有效地用于靶向治疗会导致几种严重医疗状况的医院用品上出现的细菌生物膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号